Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications;Les cyclodextrines amphiphiles et leurs applications. Élaboration de nanoparticules de cyclodextrines amphiphiles pour des applications biomédicales

Annales Pharmaceutiques Francaises

Volumn 68, Issue 1, 2010, Pages 12-26

  Parrot Lopez, H ^a,b,c   Perret, F ^a,b,c   Bertino Ghera, B ^a,b,c  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Amphiphilic cyclodextrin; Fluorinated cyclodextrins; Inclusion complex; Nanospheres

Indexed keywords

ACICLOVIR; ALPHA CYCLODEXTRIN DERIVATIVE; NANOPARTICLE;

COMPLEX FORMATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSFORMATION; FLUORINATION; NANOENCAPSULATION; NANOPHARMACEUTICS; PHYSICAL CHEMISTRY; REVIEW; SULFONATION;

CYCLODEXTRINS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; EXCIPIENTS; MOLECULAR CONFORMATION; NANOPARTICLES; PARTICLE SIZE;

EID: 77049100930     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2009.12.002     Document Type: Review

References (41)

1. Kawabata Y., Matsumoto M., Tanaka M., Takahashi H., Irinatsu Y., Tamara S., et al. Formation and deposition of monolayers of amphiphilic β-cyclodextrin derivatives. Chem Lett 11 (1986) 1933-1934
2. Ling C.C., Darcy R., and Risse W. Cyclodextrin liquid crystals: synthesis and self-organisation of amphiphilic thio-β-cyclodextrins. Chem Commun (1993) 438-440
3. Gadelle A., and Defaye J. Selective halogenation of cyclic maltose oligosaccharides in the C-6 position and synthesis of per(3,6-anhydro) cyclic maltose oligosaccharides. Angew Chem Int Ed Engl 30 1 (1991) 78-80
4. Gallois-Montbrun D., Thiebault N., Moreau V., Le Bas G., Archambault J.-C., Lesieur S., et al. Direct synthesis of novel amphiphilic cyclodextrin. J Incl Phenom Macrocycl Chem 57 1-4 (2007) 131-135
5. Memisoglu E., Bochot A., Sen M., Charon D., Duchêne D., and Hincal A.A. Intravitreal delivery of oligonucleotides by sterically stabilized liposomes. J Pharm Sci 91 5 (2002) 1214-1224
6. Zhang P., Ling C.C., Coleman A.W., Parrot-Lopez H., and Galons H. Formation of amphiphilic cyclodextrins via hydrophobic esterification at the secondary hydroxyl face. Tetrahedron Lett 32 24 (1991) 2769-2770
7. Lesieur S., Charon D., Lesieur P., Ringard-Lefebvre C., Muguet V., Duchêne D., et al. Phase behavior of fully hydrated DMPC-amphiphilic cyclodextrin systems. Chem Phys Lipids 106 (2000) 127-144
8. Khan A.R., Forgo P., Stine K.J., and D'Souza V.T. Methods for selective modifications of cyclodextrins. Chem Rev 98 5 (1998) 1977-1996
9. Canceill J., Jullien L., Lacombe L., and Lehn J.-M. Channel-type molecular structures. Part 2. Synthesis of bouquet-shaped molecules based on a β-cyclodextrin core. Helv Chim Acta 75 3 (1992) 791-812
10. Wenz G. Synthesis and characterization of some lipophilic per(2,6-di-O-alkyl)cyclomaltooligosaccharides. Carbohydr Res 214 (1991) 257-265
11. Falvey P., Lim W.C., Darcy R., Revermann T., Karst U., Giesbers M., et al. Bilayer vesicles of amphiphilic cyclodextrins: host membranes that recognize guest molecules. Chem Eur J 11 (2005) 1171-1780
12. Salameh A., Lazar A.N., Coleman A.W., and Parrot-Lopez H. Synthesis and interfacial properties of amphiphilic β-cyclodextrins and their substitution at the O-6 position with a mono bio-recognizable galactosyl antenna. Tetrahedron 61 36 (2005) 8740-8745
13. Donohue R., Mazzaglia A., Ravoo B.J., and Darcy R. Cationic β-cyclodextrin bilayer vesicles. Chem Commun 23 (2002) 2864-2865
14. Diaz-Moscoso A., Balbuena P., Gomez-Garcia M., Ortiz Mellet C., Benito J.M., Le Gourriérec L., et al. Rational design of cationic cyclooligosaccharides as efficient gene delivery systems. Chem Commun 17 (2008) 2001-2003
15. Leydet A., Moullet C., Roque J.-P., Witvrouw M., Pannecouque C., and Andrei P. Polyanion inhibitors of HIV and other viruses, 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission. J Med Chem 41 25 (1998) 4927-4932
16. Kraus T., Budesinsky M., and Zavada J. General approach to the synthesis of persubstituted hydrophilic and amphiphilic β-cyclodextrin derivatives. J Org Chem 66 13 (2001) 4595-4600
17. Sallas F., and Darcy R. Amphiphilic cyclodextrins - advances in synthesis and supramolecular chemistry. Eur J Org Chem 6 (2008) 957-969
18. Uekama K., Hirayama F., and Irie T. Cyclodextrin Drug Carrier Systems. Chem Rev 98 5 (1998) 2045-2076
19. Folkman J., Weisz P.B., Joullie M.M., Li W.W., and Ewing W.R. Control of angiogenesis with synthetic heparin substitutes. Science 243 4897 (1998) 1490-1493
20. Otake T., Schols D., Witvrouw M., Naesens L., Nakashima H., Moriya T., et al. Modified cyclodextrin sulfates (mCDS11) have potent inhibitory activity against HIV and high oral bioavailability. Antiviral Chem Chemother 5 (1994) 155-161
21. Shing Y., Folkman J., Weisz P.B., Joullie M.M., and Ewing W.R. Affinity of fibroblast growth factors for β-cyclodextrin tetradecasulfate. Anal Biochem 185 (1990) 108-111
22. Weisz P.B., Joullie M.M., Hunter C.M., Kumor K.M., Zhang Z., Levine E., et al. A basic compositional requirement of agents having heparin-like cell-modulating activities. Biochem Pharmacol 54 (1997) 149-157
23. Dubes A., Bouchu D., Lamartine R., and Parrot-Lopez H. An efficient regio-specific synthetic route to multiply substituted acyl-sulfated β-cyclodextrins. Tetrahedron Lett 42 (2001) 9147-9151
24. Dubes A., Degobert G., Fessi H., and Parrot-Lopez H. Synthesis and characterization of sulfated amphiphilic α-,β- and gamma. -cyclodextrins: application to the complexation of acyclovir. Carbohydr Res 338 (2003) 2185-2193
25. Abdelwahed W., Degobert G., Dubes A., Parrot-Lopez H., and Fessi H. Sulfated and non-sulfated amphiphilic-β-cyclodextrins: Impact of their structural properties on the physicochemical properties of nanoparticles. Int J Pharm 351 (2008) 289-295
26. Sukegawa T., Furuike T., Niikura K., Yamagishi A., and Nishimura S.I. Erythrocyte-like liposomes prepared by means of amphiphilic cyclodextrin sulfates. Chem Commun 5 (2002) 430-431
27. Fessi H, Puisieux F, Devissaguet JP, Thies C. Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles, US Patent US5118528, 1988.
28. Dubes A., Parrot-Lopez H., Abdelwahed W., Degobert G., Fessi H., Shahgaldian P., et al. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm 55 3 (2003) 279-282
29. Von Plessing Rossel C., Sepulveda Carreno J., Rodriguez-Baeza M., and Alderete J.B. Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase. Quimica Nova 23 (2000) 749-752
30. Ravey J.C., and Stébé M.-J. Properties of fluorinated non-ionic surfactant-based systems and comparison with non-fluorinated systems. Colloids Surfaces A 84 (1994) 11-31
31. Braun P.J., French D., and Robyt J.F. Porcine-pancreatic α amylase hydrolysis of substrates containing 6-deoxy-D-glucose and 6-deoxy-6-fluoro-D-glucose and the specificity of subsite binding. Carbohydr Res 143 (1985) 107-116
32. Diakur J., Zuo Z., and Wiebe L.I. Synthesis and drug complexation studies with β-cyclodextrins fluorinated on the primary face. J Carbohydr Chem 18 2 (1999) 209-223
33. Skiba M., Skiba-Lahiani M., and Arnaud P. Design of nanocapsules based on novel fluorophilic cyclodextrin derivatives and their potential role in oxygen delivery. J Incl Phenom Macrocycl Chem 44 (2003) 151-154
34. Granger C.E., Felix C.P., Parrot-Lopez H.P., and Langlois B.R. Fluorine containing β-cyclodextrin: a new class of amphiphilic carriers. Tetrahedron Lett 41 (2000) 9257-9260
35. Peroche S., and Parrot-Lopez H. Novel fluorinated amphiphilic cyclodextrin derivatives: Synthesis of mono-, di- and heptakis-(6-deoxy-6-perfluoroalkylthio)-β- cyclodextrins. Tetrahedron Lett 44 2 (2002) 241-245
36. Pearce A.J., and Sinaÿ P. Diisobutylaluminum-promoted regioselective De-O-benzylation of perbenzylated cyclodextrins: a powerful new strategy for the preparation of selectively modified cyclodextrins. Angew Chem, Int Ed Engl 39 (2000) 3610-3612
37. Peroche S., Degobert G., Putaux J.L., Blanchin M.G., Fessi H., and Parrot-Lopez H. Synthesis and characterization of novel nanospheres made from amphiphilic perfluoroalkylthio-β -cyclodextrins. Eur J Pharm Biopharm 60 1 (2005) 123-131
38. Tchoreloff P., Boissonade M.M., Coleman A.W., and Baszkin A. Amphiphilic monolayers of insoluble cyclodextrins at the water/air interface. Surface Pressure and surface potential studies. Langmuir 11 (1995) 191-196
39. Bertino-Ghera B., Perret F., Baudouin A., Coleman A.W., and Parrot-Lopez H. Synthesis and characterization of O-6-alkylthio- and perfluoroalkylpropanethio-α-cyclodextrins and their O-2-,O-3-methylated analogues. New J Che 31 (2007) 1899-1906
40. Bertino-Ghera B., Perret F., Fenet B., and Parrot-Lopez H. Control of the Regioselectivity for New Fluorinated Amphiphilic Cyclodextrins: Synthesis of Di- and Tetra(6-deoxy-6-alkylthio)- and 6-(Perfluoroalkylpropanethio)-α-cyclodextrin Derivatives. J Org Chem 73 18 (2008) 7317-7326
41. Memisoǧlu E., Bochot A., Ozalp M., Şen M., and Duchêne D. Hincal, Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes. Arch Pharm Res 20 (2003) 117-125